Shifting the paradigms for tumor suppression: lessons from the p53 field.

Abstract excerpt

The TP53 gene continues to hold distinction as the most frequently mutated gene in cancer. Since its discovery in 1979, hundreds of research groups have devoted their efforts toward understanding why this gene is so frequently selected against by tumors, with the hopes of harnessing this information toward the improved therapy of cancer. The result is that this protein has been meticulously analyzed in tumor and...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Genes, p53
• Share to Mutation
• Share to Neoplasms